Antiva Biosciences, Inc. — Form D/A

Antiva Biosciences, Inc. of Redwood City, CA, a company, filed a Form D amendment with the SEC on 2024-10-11. The offering totals $53.0M, of which $38.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (41)

Showing 25 of 41 people.

NameRoleLocation
Kristine BallDirectorRedwood City, CA
Brian GoodmanDirectorRedwood City, CA
Wende HuttonDirectorMenlo Park, CA
Gail MaderisDirectorRedwood City, CA
Beni RovinskiDirectorRedwood City, CA
Clifford SamuelDirectorRedwood City, CA
Florencia SegalDirectorRedwood City, CA
Kristine BallExecutive OfficerRedwood City, CA
Elaine ChienExecutive OfficerRedwood City, CA
Raju GadirajuExecutive OfficerRedwood City, CA
Sarah WalterExecutive OfficerRedwood City, CA
David P KabakoffDirectorBeltsville, MD
Steven JamesDirectorREDWOOD CITY, CA
Gail MaderisExecutive OfficerRedwood City, CA
Michael CannonDirectorEmeryville, CA
Oranee DanielsExecutive OfficerBRISBANE, CA
Jenny YipDirectorBRISBANE, CA
Benjamin RovinskiDirectorMendham, NJ
Vinzenz PloererDirectorBrisbane, CA
David KabakoffDirectorBrisbane, CA
Michael D CannonDirectorEmeryville, CA
John W SaywardExecutive OfficerSuwanee, GA
Vinzenz P PloererDirectorCambridge, MA
Steven P JamesDirectorSouth San Francisco, CA
David P Kabakoff, Ph.D.DirectorSouth San Francisco, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2023-05-05D$53.0M$26.6M
2021-11-03D$31.0M$15.6M
2018-07-19D$15.0M$15.0M
2017-08-28D/A$25.9M$14.7M
2017-04-05D$22.3M$11.1M
2015-06-11D$16.0M$8.9M
2014-12-23D$2.5M$1.7M
2014-07-10D$1.3M$1.1M
2013-09-05D/A$1.1M$1.1M
2013-03-06D$1.0M$501K

More